1,2,3,4-tetrahydro-1-phenylisoquinoline has been researched along with Alzheimer Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gregori-Puigjané, E; Mestres, J; Montolio, M; Navarro, P; Pineda, D | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydro-1-phenylisoquinoline and Alzheimer Disease
Article | Year |
---|---|
Identification of small molecule inhibitors of amyloid β-induced neuronal apoptosis acting through the imidazoline I(2) receptor.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cells, Cultured; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Imidazoline Receptors; In Situ Nick-End Labeling; Mice; Molecular Structure; Monoamine Oxidase; Neurons; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Structure-Activity Relationship | 2012 |